Search research articles
Contact Us
Filters
Showing results (291-300 of 319) with videos related to
Page
of 32
Sort By:
Contemporary Clinical Trials
|
March 4, 2026
Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: The EQUIVALENCE trial protocol
Samuel T Wilkinson, Sandhya Prashad, Rachel Dalthorp, et al.
Depression and Anxiety
|
November 11, 2021
Pharmacological and somatic treatment effects on suicide in adults: A systematic review and meta-analysis
Samuel T Wilkinson, Daniel Trujillo Diaz, Zachary W Rupp, et al.
Focus (American Psychiatric Publishing)
|
May 18, 2023
Pharmacological and Somatic Treatment Effects on Suicide in Adults: A Systematic Review and Meta-Analysis
Samuel T Wilkinson, Daniel Trujillo Diaz, Zachary W Rupp, et al.
Pediatric Quality & Safety
|
May 30, 2023
Pediatric Trauma and Posttraumatic Symptom Screening at Well-child Visits
Stephen S DiGiovanni, Rebecca J Hoffmann Frances, Rebecca S Brown, et al.
The International Journal of Neuropsychopharmacology
|
August 22, 2022
A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine
Bartholt Bloomfield-Clagett, Elizabeth D Ballard, Deanna K Greenstein, et al.
The Journal of Clinical Psychiatry
|
May 7, 2026
Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention: The CBT-ENDURE Randomized Trial
Samuel T Wilkinson, Brandon M Kitay, Matthew Macaluso, et al.
Leukemia & Lymphoma
|
October 10, 2009
Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV
Sarah T Wilkinson, Diane R Fernandez, Shawn P Murphy, et al.
Journal of Molecular Biology
|
December 14, 2016
Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
B Popovic, J Breed, D G Rees, et al.
Psychiatry Research
|
November 7, 2023
Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol
Brandon M Kitay, Eva Murphy, Matthew Macaluso, et al.
Nuclear Physics. A
|
August 15, 2022
Excitation function of <sup>54</sup>Fe(p,<i>α</i>)<sup>51</sup>Mn from 9.5 MeV to 18 MeV
Wilson Lin, John T Wilkinson, Kendall E Barrett, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 319) with videos related to
Sort By:
Page
of 32
Contemporary Clinical Trials
|
March 4, 2026
Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: The EQUIVALENCE trial protocol
Samuel T Wilkinson, Sandhya Prashad, Rachel Dalthorp, et al.
Depression and Anxiety
|
November 11, 2021
Pharmacological and somatic treatment effects on suicide in adults: A systematic review and meta-analysis
Samuel T Wilkinson, Daniel Trujillo Diaz, Zachary W Rupp, et al.
Focus (American Psychiatric Publishing)
|
May 18, 2023
Pharmacological and Somatic Treatment Effects on Suicide in Adults: A Systematic Review and Meta-Analysis
Samuel T Wilkinson, Daniel Trujillo Diaz, Zachary W Rupp, et al.
Pediatric Quality & Safety
|
May 30, 2023
Pediatric Trauma and Posttraumatic Symptom Screening at Well-child Visits
Stephen S DiGiovanni, Rebecca J Hoffmann Frances, Rebecca S Brown, et al.
The International Journal of Neuropsychopharmacology
|
August 22, 2022
A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine
Bartholt Bloomfield-Clagett, Elizabeth D Ballard, Deanna K Greenstein, et al.
The Journal of Clinical Psychiatry
|
May 7, 2026
Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention: The CBT-ENDURE Randomized Trial
Samuel T Wilkinson, Brandon M Kitay, Matthew Macaluso, et al.
Leukemia & Lymphoma
|
October 10, 2009
Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV
Sarah T Wilkinson, Diane R Fernandez, Shawn P Murphy, et al.
Journal of Molecular Biology
|
December 14, 2016
Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
B Popovic, J Breed, D G Rees, et al.
Psychiatry Research
|
November 7, 2023
Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol
Brandon M Kitay, Eva Murphy, Matthew Macaluso, et al.
Nuclear Physics. A
|
August 15, 2022
Excitation function of <sup>54</sup>Fe(p,<i>α</i>)<sup>51</sup>Mn from 9.5 MeV to 18 MeV
Wilson Lin, John T Wilkinson, Kendall E Barrett, et al.
Page
of 32